FluoroRing

Primarily engaged in chemical R&D, serving from gram-scale process development to commercial production.

FluoroRing

Primarily engaged in chemical R&D, serving from gram-scale process development to commercial production.

FluoroRing

Primarily engaged in chemical R&D, serving from gram-scale process development to commercial production.

Our products

More products

ABOUT US


Founded in 2004, formerly known as Shanghai Jongli Chemical, renamed as Shanghai Fluoring Pharmaceutical Technology co., Ltd. in 2016, Fluoring is a R&D company with 32 employees, including 2 PhDs, mainly engaged in chemical R&D, from gram-scale process development to commercialization of large-scale production services.

2004
3
120
85
200

Our service

Mainly engaged in new compound development, synthesis customization, process validation, and optimization in the fields of pharmaceuticals, pesticides, new materials, etc. There are 6 fume hoods and a third-party testing platform with instruments such as NMR, liquid phase, gas phase and other fields.

Picture Name

High precision distillation

View Details
Picture Name

Grignard reaction

View Details
Picture Name

Fluorination reation

View Details
Picture Name

Asymmetric synthesis

View Details
Picture Name

Foucault reaction

View Details

News

07-28

New drug research and development: technology-driven innovation, a leader in a healthy future

New drug research and development is an important field that drives innovation with science and technology and leads the future of health. This article will elaborate on new drug research and development from four aspects. First, the significance and goals of new drug research and development are introduced. Secondly, the application of science and technology in drug research and development, including machine learning, gene editing, etc., is discussed. Then, the challenges and solutions of new drug research and development, such as cooperation models and policy support, are discussed. After that, the importance of new drug research and development and its leading role in future health are summarized.

01-10

The first in the country! The group standard for the conversion of high-value biomedical patents is released: providing "patient capital" support for cutting-edge scientific teams (attached with biomedical R&D investment)

On April 19, the first national group standard "Guidelines for the Transformation of Biomedical High-Value Patents Supported by Science and Technology Innovation Finance" was officially released in Shanghai. Zheng Huiqiang, president of the Shanghai Federation of Modern Service Industries, said at the meeting that scientists have had a large number of high-value patents that need to be transformed for a long time, but the lack of long-term R&D funding support has seriously restricted the transformation of scientific and technological achievements and the implementation of applied R&D. It can be seen that it is of great significance to provide sufficient financial guarantees for the "frontier scientist team", improve their scientific research efficiency, and allow them to play a demonstration and leading role without worries.

11-12

Technological innovation is the key to core competitiveness

We have two production bases in Shanxi and Henan. The Shanxi production base is located in Fenglingdu Economic Development Zone, Shanxi Province, covering an area of ​​85 acres, with 3 workshops and a total of 120 conventional reactors, the smallest reactor is 500L, the largest is 5000L, and the designed production capacity is about 200 cubic meters. It can carry out fluorination, bromination, amination, Grignard reaction, high-precision distillation and other reactions, and can undertake CDMO projects.

Customer service

Mainly engaged in the development of new compounds, synthesis customization, process validation and optimization, involving fields such as pharmaceuticals, pesticides, new materials, etc. There are 6 fume hoods, and a third-party testing platform with instruments including NMR, liquid phase, gas phase and other fields.

Contact Us